You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
华东医药(000963.SZ)入股诺灵生物 打造ADC产业链闭环
阿思达克 04-20 08:33
华东医药(000963.SZ)宣布增资入股诺灵生物。其中,全资子公司中美华东出资1,500万元人民币(下同),华东医药参与设立的医药产业基金「福广鸿信」出资2000万元,交易完成後,中美华东和福广鸿信分别持有诺灵生物4.4776%和5.9702%股权。同时,截至2026年之前华东医药享有诺灵生物产品优先受让权。

诺灵生物是一家专注於新一代高分子ADC药物研发的创新企业。公司认为,诺灵生物的专利平台技术,对公司打造ADC药物产业链生态圈闭环具有重要的战略意义,能够与公司形成强力协同。未来待诺灵生物在研产品取得研发进展後,公司将与诺灵生物在ADC药物产品层面产生更广泛、更深层次的合作。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account